RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Clinical trial NCT06389591 · RECRUITING

Trial details

NCT number: NCT06389591
Sponsor: University of Florida
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2024-12-02
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.